Anavex Faces Fraud Suit: Key Details for Investors
A Crunch Point for Anavex Life Sciences Investors This ain't the kind of news you want hitting your ticker tape—Anavex Life Sciences Corp. (NASDAQ: AVXL) has been slapped with a securities fraud class action. The beef? Allegedly they made some less-than-stellar statements to their investors during a critical time frame. We're talking from November 26, 2025, to August...
Continue Reading